XML 116 R38.htm IDEA: XBRL DOCUMENT v2.4.1.9
Schedule I (Tables)
12 Months Ended
Dec. 31, 2014
Condensed Financial Statements, Captions [Line Items]  
Schedule of Maturities of Long-term Debt [Table Text Block]
Maturities of commercial paper and long-term debt for the years ending December 31 are as follows:
(in millions)
 
 
2015
 
$
1,396

2016
 
1,121

2017
 
1,980

2018
 
1,103

2019
 
1,027

Thereafter
 
10,870

Parent [Member]  
Condensed Financial Statements, Captions [Line Items]  
Condensed Balance Sheet [Table Text Block]
Condensed Financial Information of Registrant
(Parent Company Only)
UnitedHealth Group
Condensed Balance Sheets
 
(in millions, except per share data)
 
December 31,
2014
 
December 31,
2013
Assets
 
 
 
 
Current assets:
 
 
 
 
Cash and cash equivalents
 
$
559

 
$
822

Short-term notes receivable from subsidiaries
 
27

 
11

Deferred income taxes and other current assets
 
271

 
214

Total current assets
 
857

 
1,047

Equity in net assets of subsidiaries
 
44,643

 
44,301

Long-term notes receivable from subsidiaries
 
4,635

 
4,215

Other assets
 
278

 
144

Total assets
 
$
50,413

 
$
49,707

 
 
 
 
 
Liabilities and shareholders’ equity
 
 
 
 
Current liabilities:
 
 
 
 
Accounts payable and accrued liabilities
 
$
332

 
$
335

Note payable to subsidiary
 
215

 
215

Commercial paper and current maturities of long-term debt
 
1,365

 
1,935

Total current liabilities
 
1,912

 
2,485

Long-term debt, less current maturities
 
15,891

 
14,804

Deferred income taxes and other liabilities
 
156

 
269

Total liabilities
 
17,959

 
17,558

Commitments and contingencies (Note 4)
 
 
 
 
Shareholders’ equity:
 
 
 
 
Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding
 

 

Common stock, $0.01 par value - 3,000 shares authorized; 954 and 988 issued and outstanding
 
10

 
10

Retained earnings
 
33,836

 
33,047

Accumulated other comprehensive loss
 
(1,392
)
 
(908
)
Total UnitedHealth Group shareholders’ equity
 
32,454

 
32,149

Total liabilities and shareholders’ equity
 
$
50,413

 
$
49,707

Condensed Statement of Comprehensive Income [Table Text Block]
Condensed Financial Information of Registrant
(Parent Company Only)
UnitedHealth Group
Condensed Statements of Comprehensive Income
 
 
 
For the Years Ended December 31,
(in millions)
 
2014
 
2013
 
2012
Revenues:
 
 
 
 
 
 
Investment and other income
 
$
293

 
$
252

 
$
28

Total revenues
 
293

 
252

 
28

Operating costs:
 
 
 
 
 
 
Operating costs
 
1

 
(9
)
 
(2
)
Interest expense
 
554

 
618

 
566

Total operating costs
 
555

 
609

 
564

Loss before income taxes
 
(262
)
 
(357
)
 
(536
)
Benefit for income taxes
 
96

 
130

 
192

Loss of parent company
 
(166
)
 
(227
)
 
(344
)
Equity in undistributed income of subsidiaries
 
5,785

 
5,852

 
5,870

Net earnings
 
5,619

 
5,625

 
5,526

Other comprehensive loss
 
(484
)
 
(1,346
)
 
(23
)
Comprehensive income
 
$
5,135

 
$
4,279

 
$
5,503

Condensed Cash Flow Statement [Table Text Block]
Condensed Financial Information of Registrant
(Parent Company Only)
UnitedHealth Group
Condensed Statements of Cash Flows
 
 
 
For the Years Ended December 31,
(in millions)
 
2014
 
2013
 
2012
Operating activities
 
 
 
 
 
 
Cash flows from operating activities
 
$
7,445

 
$
5,099

 
$
6,116

Investing activities
 
 
 
 
 
 
Issuance of notes to subsidiaries
 
(436
)
 
(1,517
)
 
(4,149
)
Repayments of notes receivable from subsidiaries
 

 
275

 

Cash paid for acquisitions
 
(1,852
)
 
(274
)
 
(3,737
)
Capital contributions to subsidiaries
 
(704
)
 
(942
)
 
(99
)
Other, net
 
(9
)
 

 

Cash flows used for investing activities
 
(3,001
)
 
(2,458
)
 
(7,985
)
Financing activities
 
 
 
 
 
 
Common stock repurchases
 
(4,008
)
 
(3,170
)
 
(3,084
)
Proceeds from common stock issuances
 
462

 
598

 
1,078

Cash dividends paid
 
(1,362
)
 
(1,056
)
 
(820
)
(Repayments of) proceeds from commercial paper, net
 
(794
)
 
(474
)
 
1,587

Proceeds from issuance of long-term debt
 
1,997

 
2,235

 
3,966

Repayments of long-term debt
 
(812
)
 
(943
)
 
(986
)
Proceeds of note from subsidiary
 

 
40

 
30

Other
 
(190
)
 
(74
)
 
(383
)
Cash flows (used for) from financing activities
 
(4,707
)
 
(2,844
)
 
1,388

Decrease in cash and cash equivalents
 
(263
)
 
(203
)
 
(481
)
Cash and cash equivalents, beginning of period
 
822

 
1,025

 
1,506

Cash and cash equivalents, end of period
 
$
559

 
$
822

 
$
1,025

 
 
 
 
 
 
 
Supplemental cash flow disclosures
 
 
 
 
 
 
Cash paid for interest
 
$
578

 
$
618

 
$
547

Cash paid for income taxes
 
4,028

 
2,765

 
2,666

Schedule of Maturities of Long-term Debt [Table Text Block]
Maturities of commercial paper and long-term debt for the years ending December 31 are as follows:
(in millions)
 
 
2015
 
$
1,362

2016
 
1,096

2017
 
1,972

2018
 
1,100

2019
 
1,000

Thereafter
 
10,817